Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Ptácek, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Ptácek, L. J.
Neurology 2000;54:937-942
© 2000 American Academy of Neurology


Articles

Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita

Jie Zhang, MS, Saïd Bendahhou, PhD, Michael C. Sanguinetti, PhD and Louis J. Ptácek, MD

From the Department of Neurology (J. Zhang and Dr. Ptácek), Department of Human Genetics (Dr. Ptácek), Program in Neuroscience (J. Zhang, Drs. Sanguinetti, and Ptácek), Department of Internal Medicine (Dr. Sanguinetti), and the Howard Hughes Medical Institute (Drs. Bendahhou and Ptácek), University of Utah, Salt Lake City, UT.

Address correspondence and reprint requests to Dr. L.J. Ptácek, Howard Hughes Medical Institute, University of Utah, Building 533, Room 4420, 15N 2030 East, Salt Lake City, UT 84112-5331.

OBJECTIVE: To determine the functional consequences of missense mutations within the skeletal muscle chloride channel gene CLCN1 that cause myotonia congenita.

BACKGROUND: Myotonia congenita is a genetic muscle disease associated with abnormalities in the skeletal muscle voltage-gated chloride (ClC-1) channel. In order to understand the molecular basis of this inherited disease, it is important to determine the physiologic consequences of mutations found in patients affected by it.

METHODS: The authors used a mammalian cell (human embryonic kidney 293) expression system and the whole-cell voltage-clamp technique to functionally express and physiologically characterize five CLCN1 mutations.

RESULTS: The I329T mutation shifted the voltage dependence of open probability of ClC-1 channels to the right by 192 mV, and the R338Q mutation shifted it to the right by 38 mV. In addition, the I329T ClC-1 channels deactivated to a lesser extent than normal at negative potentials. The V165G, F167L, and F413C ClC-1 channels also shifted the voltage dependence of open probability, but only by +14 to +20 mV.

CONCLUSIONS: The functional consequences of these mutations form the physiologic argument that these are disease-causing mutations and could lead to myotonia congenita by impairing the ability of the skeletal muscle voltage-gated chloride channels to maintain normal muscle excitability. Understanding of genetic and physiologic defects may ultimately lead to better diagnosis and treatment of patients with myotonia congenita.

Key words: Chloride channel—Mutation—Function—Myotonia—Neuromuscular diseases—Electrophysiology—Genetics




This article has been cited by other articles:


Home page
BrainHome page
E. Matthews, D. Fialho, S. V. Tan, S. L. Venance, S. C. Cannon, D. Sternberg, B. Fontaine, A. A. Amato, R. J. Barohn, R. C. Griggs, et al.
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment
Brain, November 16, 2009; (2009) awp294v1.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T.-Y. Chen and T.-C. Hwang
CLC-0 and CFTR: Chloride Channels Evolved From Transporters
Physiol Rev, April 1, 2008; 88(2): 351 - 387.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Fialho, S. Schorge, U. Pucovska, N. P. Davies, R. Labrum, A. Haworth, E. Stanley, R. Sud, W. Wakeling, M. B. Davis, et al.
Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions
Brain, December 1, 2007; 130(12): 3265 - 3274.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Ryan, R. Rudel, M. Kuchenbecker, and C. Fahlke
A novel alteration of muscle chloride channel gating in myotonia levior
J. Physiol., December 1, 2002; 545(2): 345 - 354.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
F.-F. Wu, A. Ryan, J. Devaney, M. Warnstedt, Z. Korade-Mirnics, B. Poser, M. J. Escriva, E. Pegoraro, A. S. Yee, K. J. Felice, et al.
Novel CLCN1 mutations with unique clinical and electrophysiological consequences
Brain, November 1, 2002; 125(11): 2392 - 2407.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Warnstedt, C. Sun, B. Poser, M. J. Escriva, L. Tranebjarg, T. Torbergsen, M. van Ghelue, and C. Fahlke
The Myotonia Congenita Mutation A331T Confers a Novel Hyperpolarization-Activated Gate to the Muscle Chloride Channel ClC-1
J. Neurosci., September 1, 2002; 22(17): 7462 - 7470.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. D. Edmonds, I. V. Silva, W. B. Guggino, R. B. Butler, P. L. Zeitlin, and C. J. Blaisdell
Pre- and Postnatal Lung Development, Maturation, and Plasticity: ClC-5: ontogeny of an alternative chloride channel in respiratory epithelia
Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L501 - L507.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.